billHR5183Event Tuesday, January 27, 2026Analyzed

District of Columbia Home Rule Improvement Act of 2025

Neutral

Summary

HR5183 is a procedural bill extending congressional review of DC laws from 30 to 60 days and expanding disapproval authority to regulations. It authorizes no funding, creates no market-moving mechanism, and has no direct impact on any publicly traded company. The bill is active but stalled on the Union Calendar since January 2026.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.No funding authorized or appropriated
  • 2.No private sector impact
  • 3.Bill stalled since January 2026
  • 4.Companion bill S4150 also inactive

Market Implications

This bill has no implications for any publicly traded company. It is a procedural change to how Congress reviews District of Columbia laws and does not affect federal spending, procurement, or regulation of any private sector entity.

Full Analysis

HR5183, the District of Columbia Home Rule Improvement Act, was introduced in September 2025 by Rep. Gosar (R-AZ) and has three cosponsors. It was reported amended by the Committee on Oversight and Government Reform on January 27, 2026, and placed on the Union Calendar. Since then, no further floor action has occurred. The bill extends the congressional review period for DC nonemergency laws from 30 to 60 days and allows Congress to disapprove specific provisions, regulations, and executive orders. It does not authorize or appropriate any federal funds. No publicly traded companies are affected because the bill targets the legislative process of the District of Columbia, not any commercial activity. The companion bill S4150 is also in early stages. Without any funding, procurement, or regulatory change impacting private enterprise, the market impact is nil.

Key Legislators

Rep. Gosar, Paul A. [R-AZ-9]